It is currently facing some company-specific challenges, including a complicated merger and operations in politically ...

The stock has dropped over 44% so far this year after reporting weaker-than-expected earnings in the first quarter.

Amgen Inc. (NASDAQ:AMGN) is on the hunt for its next breakthrough drug— a common pursuit among pharmaceutical companies ...

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...